Yahoo Web Search

  1. It has been about a month since the last earnings report for Regeneron (REGN). Regeneron delivered impressive results in the fourth quarter of 2018, wherein both earnings and sales beat estimates ...

  2. Regeneron-Sanofi Get CHMP Nod for Dupixent Label Expansion

    Zacks via Yahoo FinanceMar 04 22:15 PM

    Regeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion ...

  3. Ltd. has asked a federal judge to toss a $155 million jury verdict last month finding that it had infringed a patent for Bayer AG's hemophilia treatment. According to Baxalta, ...

  4. Regeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced that the FDA has approved a label expansion of asthma drug Dupixent (dupilumab). Dupixent, a targeted biologic therapy that ...

  5. The Zacks Large Cap Pharmaceuticals industry comprises some of the largest global companies that develop multi-million dollar drugs for a broad range of therapeutic areas such as neuroscience ...

  6. Regeneron Pharmaceuticals, Inc. REGN announced that the European Commission (EC) has approved a label expansion of its PCSK9 inhibitor, Praluent. The drug’s label has been expanded to reduce ...